Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Non-Current Deffered Revenue (2018 - 2019)

Historic Non-Current Deffered Revenue for Champions Oncology (CSBR) over the last 2 years, with Q2 2019 value amounting to $851000.0.

  • Champions Oncology's Non-Current Deffered Revenue rose 8744.49% to $851000.0 in Q2 2019 from the same period last year, while for Apr 2019 it was $851000.0, marking a year-over-year increase of 8744.49%. This contributed to the annual value of $851000.0 for FY2019, which is 8744.49% up from last year.
  • Latest data reveals that Champions Oncology reported Non-Current Deffered Revenue of $851000.0 as of Q2 2019, which was up 8744.49% from $733000.0 recorded in Q1 2019.
  • In the past 5 years, Champions Oncology's Non-Current Deffered Revenue ranged from a high of $851000.0 in Q2 2019 and a low of $454000.0 during Q2 2018